Paraoxonase Activity and Expression Is Modulated by Therapeutics in Experimental Rat Nonalcoholic Fatty Liver Disease
Objective. The objective of the present study is to investigate the effect of rosiglitazone, metformin, ezetimibe, and valsartan (alone or in combinations) on paraoxonase (PON) activity and PON-mRNA expression in nonalcoholic fatty liver disease (NAFLD). Methods. 54 Male Sprague–Dawley rats were div...
Main Authors: | O. Hussein, J. Zidan, K. Abu Jabal, I. Shams, S. Szvalb, M. Grozovski, I. Bersudsky, R. Karry, M. Aviram |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2012/265305 |
Similar Items
-
Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol[S]
by: Eline H. van den Berg, et al.
Published: (2019-01-01) -
Introduction to Paraoxonases
by: Michael Aviram
Published: (2012-01-01) -
Focus on Therapeutic Strategies of Nonalcoholic Fatty Liver Disease
by: Marilena Durazzo, et al.
Published: (2012-01-01) -
Serum paraoxonase as an indicator for fatty liver in sheep
by: Cao Yu, et al.
Published: (2017-03-01) -
Nonalcoholic fatty liver disease
by: Lafaine M. Grant, et al.
Published: (2004-07-01)